A Real-World Descriptive Study of Renal Outcomes Among Patients with ANCA-Associated Vasculitis Initiating Remission Induction Therapy

被引：0
|
作者：
Oh, Sam [1 ]
Inguva, Sushmitha [2 ]
Rane, Pallavi [2 ]
Tumminello, Brian [3 ]
机构：
[1] Amgen Inc, San Francisco, CA USA
[2] Amgen Inc, Thousand Oaks, CA USA
[3] Amgen Inc, San Juan Capistrano, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2379
引用
收藏
页码：4715 / 4717
页数：3
相关论文
共 50 条
  • [41] Determinants of renal and patient outcomes in a Spanish cohort of patients with ANCA-associated vasculitis and renal involvement
    H. Marco
    J. Draibe
    J. Villacorta
    L. F. Quintana
    N. Martin
    R. Garcia-Osuna
    C. Cabre
    MA. Martín-Gómez
    A. Balius
    A. Saurina
    M. Picazo
    I. Gich-Saladich
    M. Navarro-Díaz
    M. Praga
    T. Cavero
    J. Ballarin
    M M Díaz-Encarnación
    Clinical Rheumatology, 2018, 37 : 1065 - 1074
  • [42] RENAL DAMAGE IN ANCA-ASSOCIATED VASCULITIS IN INCIDENT AND RELAPSING PATIENTS - PATTERNS AND PROGRESSION USING REAL WORLD DATA
    Rutherford, Peter
    Gotte, Dieter
    Worthington, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 346 - 346
  • [43] CLINICAL PROFILE AND HEALTHCARE RESOURCE USE OF ANCA-ASSOCIATED VASCULITIS: A REAL-WORLD ANALYSIS IN ITALY
    Perrone, V
    Dovizio, M.
    Veronesi, C.
    Andretta, M.
    Bacca, M.
    Barbieri, A.
    Bartolini, F.
    Cavaliere, A.
    Chinellato, A.
    Ciaccia, A.
    Cillo, M. R.
    Citraro, R.
    Costantini, A.
    Dell'Orco, S.
    Ferrante, F.
    Gentile, S.
    Grego, S.
    Lavalle, A.
    Mancini, D.
    Moscogiuri, R.
    Mosele, E.
    Pagliaro, R.
    Procacci, C.
    Re, D.
    Santoleri, F.
    Ubertazzo, L.
    Vercellone, A.
    Serna, Ramirez de Arellano A.
    Degli Esposti, L.
    VALUE IN HEALTH, 2022, 25 (12) : S29 - S29
  • [44] CYCLOPHOSPHAMIDE INDUCTION TREATMENT IN ANCA-ASSOCIATED VASCULITIS WITH RENAL AND PULMONARY INVOLVEMENT: OUTCOMES AND SIDE EFFECTS
    Vezzani, Valeria
    Di Vito, Roberto
    Orfeo, Chiara Alessia
    Capone, Martina
    Iarlori, Luigia
    Marra, Pietro
    Nolletti, Lorenzo
    Bonomini, Andmario
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I351 - I351
  • [45] Renal improvement and remission in a patient with refractory ANCA-associated vasculitis treated with avacopan
    Alvarez, Luis
    Kambham, Neeraja
    Su, Robert
    JOURNAL OF NEPHROLOGY, 2023, 36 (08) : 2365 - 2370
  • [46] Renal improvement and remission in a patient with refractory ANCA-associated vasculitis treated with avacopan
    Luis Alvarez
    Neeraja Kambham
    Robert Su
    Journal of Nephrology, 2023, 36 : 2365 - 2370
  • [47] LONG TERM OUTCOMES OF PATIENTS WITH ANCA-ASSOCIATED VASCULITIS PRESENTING WITH SEVERE RENAL DYSFUNCTION
    Mcadoo, Stephen
    Tanna, Anisha
    Kang, Amy
    Azam, Sultana
    Gulati, Kavita
    Tam, Frederick
    Griffith, Megan
    Cairns, Thomas
    Levy, Jeremy
    Pusey, Charles
    RHEUMATOLOGY, 2019, 58 : 115 - 115
  • [48] When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy?
    Oliver Flossmann
    Kirsten de Groot
    Nature Clinical Practice Nephrology, 2007, 3 : 236 - 237
  • [49] LOW-DOSE RITUXIMAB AS INDUCTION THERAPY FOR JAPANESE PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Takakuwa, Y.
    Hanaoka, H.
    Kiyokawa, T.
    Ishimori, K.
    Iida, H.
    Nagafuchi, H.
    Okazaki, T.
    Ozaki, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1260 - 1260
  • [50] MAINTENANCE TREATMENT FOR ANCA-ASSOCIATED VASCULITIS IN REAL WORLD PRACTICE IN EUROPE REALITY OF VASCULITIS REMISSION AND RELAPSE AND SIGNIFICANT BURDEN OF DISEASE
    Rutherford, P.
    Gotte, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 21 - 22
12345